Similarly, Kitagawa et al. reported messenger RNAs WASF2 and ARF6, and small nucleolar RNAs SNORA74A and SNORA25, can each distinguish pancreatic cancer patients from healthy controls with an AUROC of >0.9, including for patients with stage I/II disease [74]. Here, WASF2 is linked to pancreatic neoplasm.